NanoViricides Inc. (NNVC) Stock Quote

Detailed Quote for NanoViricides Inc. (NNVC)

close 52 Week Information

52 Week High

April 13, 2011

Close: 1.65

52 Week Low

January 24, 2012

Close: 0.52

Today

Last Price
0.75

Change $
0.0301

Change %
4.18%

Tick
N/A

Bid
0.68

Bid Size
2,500

Ask
0.90

Ask Size
2,500

Open
0.78

High
0.7877

Low
0.7101

Prev Close
0.7199

Last Trade
3:58

Volume
504.21 k

52 Wk Hi
1.65

52 Wk Low
0.52

Market Cap
110.2 m

Ex-Div Date
N/A

Div Rate
N/A

Yield
N/A

Shares
146,937,064

EPS (TTM)
-0.03

PE Ratio
N/A

close Exchange Information Listed On OTC Bulletin Board Consolidated (OTCBB) Exchange
OTCBB

News and Media for NanoViricides Inc. (NNVC)

Sector News | Topic News

News for NNVC

Tue, Jan 31, 2012

7:00 AM

NanoViricides Inc. Submits Pre-IND Briefing Document for its Anti-Influenza drug, FluCide(tm), to the US FDA - Business Wire

Mon, Jan 16, 2012

9:54 AM

Capital Market Conferences Continue to Pave the Way for Investor Confidence, Funding Opportunities and Economic Recovery - Marketwire

Mon, Dec 05, 2011

7:00 AM

NanoViricides, Inc. Announces That It Has Submitted a Pre-IND Meeting Request to the US FDA For Its Anti-Influenza Clinical Drug Candidate, FluCide(tm) - Business Wire

Tue, Nov 15, 2011

7:00 AM

NanoViricides Files Quarterly Report - Business Wire

Wed, Jul 06, 2011

9:00 AM

Reports on NanoViricides, Inc. and China Pharma Holdings, Inc. - New Drugs for New Bugs - Marketwire

Fri, Aug 13, 2010

12:57 PM

AllPennyStocks.com News: Junior Biotech Bounces off $1; Chart Trying to Turn Bullish - Accesswire

Tue, Apr 28, 2009

11:32 AM

Springing into action in time of need: NanoViricides, Inc. (NNVC.OB) - Accesswire

More News for NNVC >>

Tags for NanoViricides Inc.

Research stocks or mutual funds related to NanoViricides Inc. by keywords or tags. Find companies that have a similar focus to NNVC. The keywords below have been associated to NNVC by either user submission or electronic means.

Diversified Services dry eye drops dry eyes sec regulation Services Commercial Physical And Biological Research (8731) investment adviser contract nanotechnology mems pink eye sec form 4 pharmaceutical research and development conjunctivitis treatments bird flu virus mechanism of action viral diseases viral conjunctivitis accounting reports otc bulletin board sec attorneys bird flu fact pharmaceutical sales securities regulation nasd audit securities regulation law outline t cell clones eye lubricant accounting assets eye makeup allergy eye stye treatment broker dealer accounting sec 13g virus diseases h5n1 bird flu prevention pharmaceutical formulation sec lawyer trachoma treatment sec regulations accounting finance not for profit accounting accounting definition new sec regulation lubricant eye ointment sec securities viral disease financial accounting terms sec rules securities act of 1933 avian flu virus sec 13d